- Home
- TMQ vs TLRY Comparison
TMQ vs TLRY Comparison
Compare TMQ & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TMQ | TLRY |
|---|---|---|
| Founded | 2004 | N/A |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medicinal Chemicals and Botanical Products |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 705.7M | 688.9M |
| IPO Year | 2012 | 2018 |
Fundamental Metrics
Financial Performance| Metric | TMQ | TLRY |
|---|---|---|
| Price | $3.74 | $4.74 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $72.33 |
| AVG Volume (30 Days) | 2.4M | ★ 3.3M |
| Earning Date | 04-02-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.79 |
| Revenue Next Year | N/A | $19.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.30 | $0.36 |
| 52 Week High | $11.29 | $15.70 |
Technical Indicators
Market Signals| Indicator | TMQ | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 41.63 | 33.20 |
| Support Level | $3.35 | $1.12 |
| Resistance Level | $4.53 | $5.71 |
| Average True Range (ATR) | 0.28 | 0.27 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 13.64 | 10.66 |
Price Performance
Historical ComparisonAbout TMQ Trilogy Metals Inc.
Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the USA. Its properties include the Arctic copper-zinc-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.